Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × fludarabine × CNS × Clear all

Phase

Status

Recruiting 12 Terminated 5 Unknown 4 Not yet recruiting 3 Completed 3 Active not recruiting 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 21 Lymphoid 16 Myeloid 7 Gastrointestinal 7 Plasma cell 4 Gynecologic 3 Genitourinary 3 Dermatologic 3 Breast 3 Thoracic 2 Sarcoma 2 Head & Neck 2 Other solid neoplasm 1 Classical hematology 1 CNS 1

Conditions

Neuroblastoma 1

Interventions

Temozolomide 16 Magnetic Resonance Spectroscopy 13 Radiotherapy 9 Radiosurgery 9 Bevacizumab 9 Methotrexate 6 pembrolizumab 5 Specimen Handling 5 Radiation 5 Surgical Procedures, Operative 4 Isotretinoin 4 Carboplatin 4 abemaciclib 3 Trastuzumab 3 Topotecan 3 Thiotepa 3 TIC10 compound 3 Standard of Care 3 Lomustine 3 Drug Therapy 3 Dexamethasone 3 thymoglobulin 2 pazopanib 2 lutetium Lu 177 dotatate 2 keyhole-limpet hemocyanin 2 imetelstat 2 fludarabine phosphate 2 fluciclovine F-18 2 dexamethasone acetate 2 Vincristine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02439788 2017-06-14

GINAKIT

Baylor College of Medicine

Phase 1 Withdrawn

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡